These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 28176472
1. Suspected atypical haemolytic uraemic syndrome in two post-partum patients with foetal-death in utero responding to eculizumab. Chua J, Paizis K, He SZ, Mount P. Nephrology (Carlton); 2017 Feb; 22 Suppl 1():18-22. PubMed ID: 28176472 [Abstract] [Full Text] [Related]
7. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort. Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N. Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170 [Abstract] [Full Text] [Related]
9. Eculizumab in secondary atypical haemolytic uraemic syndrome. Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M. Nephrol Dial Transplant; 2017 Mar 01; 32(3):466-474. PubMed ID: 28339660 [Abstract] [Full Text] [Related]
10. Irreversible severe kidney injury and anuria in a 3-month-old girl with atypical haemolytic uraemic syndrome under administration of eculizumab. Okuda Y, Ishikura K, Terano C, Harada R, Hamada R, Hataya H, Ogata K, Honda M. Nephrology (Carlton); 2016 Mar 01; 21(3):261-5. PubMed ID: 26818219 [Abstract] [Full Text] [Related]
12. Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients. Terano C, Ishikura K, Hamada R, Yoshida Y, Kubota W, Okuda Y, Shinozuka S, Harada R, Iyoda S, Fujimura Y, Hamasaki Y, Hataya H, Honda M. Nephrology (Carlton); 2018 Jun 01; 23(6):539-545. PubMed ID: 28387984 [Abstract] [Full Text] [Related]
13. Successful treatment with eculizumab in a patient with pregnancy-associated atypical hemolytic uremic syndrome. Duran MN, Beyazit F, Erbaş M, Özkavak O, Acar C, Bakirdogen S. Obstet Med; 2023 Jun 01; 16(2):130-133. PubMed ID: 37441667 [Abstract] [Full Text] [Related]
16. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review]. Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F. G Ital Nefrol; 2019 Apr 23; 36(2):. PubMed ID: 30983177 [Abstract] [Full Text] [Related]
17. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM. Am J Kidney Dis; 2016 Jul 23; 68(1):84-93. PubMed ID: 27012908 [Abstract] [Full Text] [Related]
18. Atypical haemolytic uraemic syndrome in a postpartum patient. Hierholzer A, Majdinasab E, Young M, Kauffman RP. BMJ Case Rep; 2023 Nov 09; 16(11):. PubMed ID: 37945276 [Abstract] [Full Text] [Related]